Younger for longer: insulin signalling, immunity and ageing
Francis R G Amrit1, Robin C May
1School of Biosciences, College of Life and Environmental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Current Aging Science
|August 26, 2010
Summary
Aging is influenced by genes, environment, and lifestyle, acting through conserved pathways. The Insulin/IGF-like signaling (IIS) pathway significantly modulates lifespan across diverse animals, impacting immunity and stress resistance.
Area of Science:
- Gerontology
- Evolutionary Biology
- Molecular Biology
Background:
- Aging is a universal phenomenon influenced by genetic, environmental, and lifestyle factors.
- Evolutionarily conserved pathways regulate lifespan across a wide range of animals.
- The Insulin/IGF-like signaling (IIS) pathway is a key modulator of aging.
Purpose of the Study:
- To review the evolutionary conservation of the IIS pathway in relation to aging.
- To discuss recent findings on the molecular basis of aging.
- To explore how IIS pathway diversification explains differences in aging.
Main Methods:
- Literature review of evolutionary conservation of the IIS pathway.
- Analysis of molecular mechanisms underlying aging.
- Comparative analysis of IIS pathway function across species.
Main Results:
- The IIS pathway, conserved from yeast to mammals, coordinates processes like immunity and stress resistance to regulate longevity.
- The molecular architecture and function of the IIS pathway are highly conserved.
- Diversification of the IIS pathway impacts inter- and intra-species aging differences.
Conclusions:
- The IIS pathway is a fundamental regulator of aging, conserved across animal species.
- Understanding IIS pathway evolution provides insights into species-specific aging patterns.
- Further research into IIS pathway diversification can elucidate aging mechanisms.
Related Concept Videos
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...